VGLL3 is of interest as it may act as a tumor suppressor gene in epithelial ovarian cancer [209], but VGLL3 expression is a marker for poor outcome in stomach adenocarcinoma and in PCa [210,211]. This evidence concerns the gene VGLL3 and posterior cortical atrophy.